Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-19

Clinical Trial Update: Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease. [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating different benznidazole regimens for chronic Chagas disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benznidazole (benznidazole)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Chagas Disease, Trypanosoma Cruzi Infection | Phase 2 | Status: COMPLETED